Showing 81 - 100 results of 3,771 for search '"Cancer Management and Research"', query time: 0.26s Refine Results
  1. 81
    Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT)

    Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) by Zhang L, Ye J, Luo Q, Kuang M, Mao M, Dai S, Wang X

    Published 2020-07-01
    “…Cancer Management and Research…”
    Get full text
    Article
  2. 82
    Abnormal microRNA expression in the course of hematological malignancies

    Abnormal microRNA expression in the course of hematological malignancies by Szymczyk A, Macheta A, Podhorecka M

    Published 2018-10-01
    “…Cancer Management and Research…”
    Get full text
    Article
  3. 83
    microRNA-26a Directly Targeting MMP14 and MMP16 Inhibits the Cancer Cell Proliferation, Migration and Invasion in Cutaneous Squamous Cell Carcinoma [Retraction]

    microRNA-26a Directly Targeting MMP14 and MMP16 Inhibits the Cancer Cell Proliferation, Migration and Invasion in Cutaneous Squamous Cell Carcinoma [Retraction] by Zheng W, Li ZY, Zhao DL, Li XL, Liu R

    Published 2021-09-01
    “…Cancer Management and Research…”
    Get full text
    Article
  4. 84
    Long Non-Coding RNA XIST Promotes Wilms Tumor Progression Through the miR-194-5p/YAP Axis

    Long Non-Coding RNA XIST Promotes Wilms Tumor Progression Through the miR-194-5p/YAP Axis by He X, Luo X, Dong J, Deng X, Liu F, Wei G

    Published 2021-04-01
    “…Cancer Management and Research…”
    Get full text
    Article
  5. 85
    The Diagnostic and Prognostic Value of Serum lncRNA NEAT1 in Colorectal Cancer

    The Diagnostic and Prognostic Value of Serum lncRNA NEAT1 in Colorectal Cancer by Wang Y, Zhang D, Zhang C, Sun Y

    Published 2020-11-01
    “…Cancer Management and Research…”
    Get full text
    Article
  6. 86
    CXCR7, a Prognostic Biomarker in Cervical Squamous Cell Carcinoma, May Be a Screening Index for Treatment Options at Stages IB1 and IIA1

    CXCR7, a Prognostic Biomarker in Cervical Squamous Cell Carcinoma, May Be a Screening Index for Treatment Options at Stages IB1 and IIA1 by Zhao D, Qin W, Zhao C, Long J, Li M

    Published 2019-12-01
    “…Cancer Management and Research…”
    Get full text
    Article
  7. 87
    Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives

    Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives by Thajudeen B, Salahudeen AK

    Published 2016-08-01
    “…Cancer Management and Research…”
    Get full text
    Article
  8. 88
    Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience

    Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience by Schaefer A, Huang Y, Kittai A, Maakaron JE, Saygin C, Brammer J, Penza S, Saad A, Jaglowski SM, William BM

    Published 2021-11-01
    “…Cancer Management and Research…”
    Get full text
    Article
  9. 89
    Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphoma

    Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphoma by Aguiar-Bujanda D, Blanco-Sánchez MJ, Hernández-Sosa M, Galván-Ruíz S, Hernández-Sarmiento S

    Published 2015-10-01
    “…Cancer Management and Research…”
    Get full text
    Article
  10. 90
    miR-300 rs12894467 polymorphism may be associated with susceptibility to primary lung cancer in the Chinese Han population

    miR-300 rs12894467 polymorphism may be associated with susceptibility to primary lung cancer in the Chinese Han population by Liu Z, Lin Y, Kang S, Xu Q, Xiong W, Cai L, He F

    Published 2018-09-01
    “…Cancer Management and Research…”
    Get full text
    Article
  11. 91
    A PI-RADS-Based New Nomogram for Predicting Clinically Significant Prostate Cancer: A Cohort Study

    A PI-RADS-Based New Nomogram for Predicting Clinically Significant Prostate Cancer: A Cohort Study by Zhang Y, Zhu G, Zhao W, Wei C, Chen T, Ma Q, Zhang Y, Xue B, Shen J

    Published 2020-05-01
    “…Cancer Management and Research…”
    Get full text
    Article
  12. 92
    The Hedgehog signal transducer Smoothened and microRNA-326: pathogenesis and regulation of drug resistance in pediatric B-cell acute lymphoblastic leukemia

    The Hedgehog signal transducer Smoothened and microRNA-326: pathogenesis and regulation of drug resistance in pediatric B-cell acute lymphoblastic leukemia by Sheybani Z, Rahgozar S, Ghodousi ES

    Published 2019-08-01
    “…Cancer Management and Research…”
    Get full text
    Article
  13. 93
    Association of Venous Thromboembolism and Early Mortality in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer

    Association of Venous Thromboembolism and Early Mortality in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer by Su Y, Huo M, Hua L, Zhang Y, Yi J, Zhang S, Li J, Zhang Y

    Published 2021-05-01
    “…Cancer Management and Research…”
    Get full text
    Article
  14. 94
    Clinical management of grade III oligodendroglioma

    Clinical management of grade III oligodendroglioma by Simonetti G, Gaviani P, Botturi A, Innocenti A, Lamperti E, Silvani A

    Published 2015-07-01
    “…Cancer Management and Research…”
    Get full text
    Article
  15. 95
    Silencing of LINC01116 Suppresses the Development of Oral Squamous Cell Carcinoma by up-Regulating microRNA-136 to Inhibit FN1 [Retraction]

    Silencing of LINC01116 Suppresses the Development of Oral Squamous Cell Carcinoma by up-Regulating microRNA-136 to Inhibit FN1 [Retraction] by Chen Z, Tao Q, Qiao B, Zhang L

    Published 2022-06-01
    “…Cancer Management and Research…”
    Get full text
    Article
  16. 96
    High Risk Thyroid Nodule Discrimination and Management by Modified TI-RADS

    High Risk Thyroid Nodule Discrimination and Management by Modified TI-RADS by Li M, Wei L, Li F, Kan Y, Liang X, Zhang H, Liu J

    Published 2021-01-01
    “…Cancer Management and Research…”
    Get full text
    Article
  17. 97
    Comprehensive Analysis of 5-Methylcytosine Profiles of Messenger RNA in Human High-Grade Serous Ovarian Cancer by MeRIP Sequencing

    Comprehensive Analysis of 5-Methylcytosine Profiles of Messenger RNA in Human High-Grade Serous Ovarian Cancer by MeRIP Sequencing by Meng L, Zhang Q, Huang X

    Published 2021-08-01
    “…Cancer Management and Research…”
    Get full text
    Article
  18. 98
    Real-World Data Of Osimertinib In Patients With Pretreated Non-Small Cell Lung Cancer: A Retrospective Study

    Real-World Data Of Osimertinib In Patients With Pretreated Non-Small Cell Lung Cancer: A Retrospective Study by Mu Y, Xing P, Hao X, Wang Y, Li J

    Published 2019-10-01
    “…Cancer Management and Research…”
    Get full text
    Article
  19. 99
    MicroRNA-802 Inhibits Cell Proliferation and Induces Apoptosis in Human Laryngeal Cancer by Targeting cAMP-Regulated Phosphoprotein 19 [Retraction]

    MicroRNA-802 Inhibits Cell Proliferation and Induces Apoptosis in Human Laryngeal Cancer by Targeting cAMP-Regulated Phosphoprotein 19 [Retraction] by Ye H, Jin Q, Wang X, Li Y

    Published 2021-09-01
    “…Cancer Management and Research…”
    Get full text
    Article
  20. 100
    Comparison of Perioperative Outcomes Between Laparoscopic and Robot-Assisted Adrenalectomy for Large Pheochromocytoma (≥ 5cm): A Retrospective Study

    Comparison of Perioperative Outcomes Between Laparoscopic and Robot-Assisted Adrenalectomy for Large Pheochromocytoma (≥ 5cm): A Retrospective Study by Cheng Y, Zhu Y

    Published 2023-10-01
    “…Cancer Management and Research…”
    Get full text
    Article

Search Tools: